Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07850102) titled 'Brain Imaging of DSP-2342' on Sept. 24.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Johns Hopkins University

Condition: SCHIZOPHRENIA 1 (Disorder)

Intervention: Drug: DSP-2342

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: January 1, 2027

Target Sample Size: 20

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07850102

Published by HT Digital Content Services with permission from Health Daily D...